ABM clinical protocol #18: Use of antidepressants in nursing mothers

Breastfeeding Medicine

Volumn 3, Issue 1, 2008, Pages 44-52

  Chaudron, Linda H ^a   Giannandrea, Stephanie A M ^a   Chantry, Caroline J ^a   Howard, Cynthia R ^a   Lawrence, Ruth A ^a   Marinelli, Kathleen A ^a   Powers, Nancy G ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; AMITRIPTYLINE; AMOXAPINE; ANTIDEPRESSANT AGENT; CITALOPRAM; CLOMIPRAMINE; DESIPRAMINE; DOXEPIN; DULOXETINE; ESCITALOPRAM; FLUOXETINE; FLUVOXAMINE; HYPERICUM PERFORATUM EXTRACT; MAPROTILINE; MIRTAZAPINE; NORTRIPTYLINE; OMEGA 3 FATTY ACID; PAROXETINE; PROTRIPTYLINE; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT; TRIMIPRAMINE; VENLAFAXINE;

ALGORITHM; ANXIETY DISORDER; BREAST FEEDING; BREAST MILK; CHRONIC PAIN; CLINICAL PROTOCOL; DEPRESSION; DRUG CHOICE; DRUG EXCRETION; DRUG MILK LEVEL; DRUG SAFETY; FAMILY HISTORY; HUMAN; INFORMED CONSENT; MATERNAL WELFARE; MEDICAL DECISION MAKING; OBSESSIVE COMPULSIVE DISORDER; PATIENT MONITORING; PRACTICE GUIDELINE; PRIORITY JOURNAL; PSYCHOTHERAPY; PUERPERAL DEPRESSION; REVIEW; RISK BENEFIT ANALYSIS; SLEEP DISORDER; TREATMENT OUTCOME;

ADULT; ANTIDEPRESSIVE AGENTS; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; LACTATION; MILK, HUMAN; PHYSICIAN'S PRACTICE PATTERNS; RISK ASSESSMENT; SOCIETIES, MEDICAL; UNITED STATES;

EID: 40649097590     PISSN: 15568253     EISSN: None     Source Type: Journal    
DOI: 10.1089/bfm.2007.9978     Document Type: Review

References (71)

1. O'Hara MW, Neunaber DJ, Zekoski EM. Prospective study of postpartum depression: Prevalence, course, and predictive factors. J Abnorm Psychol 1984;93:158-171.
2. Chaudron LH, Szilagyi PG, Kitzman HJ, et al. Detection of postpartum depressive symptoms by screening at well-child visits. Pediatrics 2004;113:551-558.
3. Gaynes BN, Gavin N, Meltzer-Brody S, et al. Perinatal Depression: Prevalence, Screening Accuracy, and Screening Outcomes. Evidence Report/Technology Assessment No. 119. Prepared by the RTI-University of North Carolina Evidence-Based Practice Center, under Contract Number 290-02-0016. AHRQ Publication Number 05-E006-2. Agency for Healthcare Research and Quality, Rockville, MD, 2005.
4. Murray L, Hipwell A, Hooper R, et al. The cognitive development of 5-year-old children of postnatally depressed mothers. J Child Psychol Psychiatry 1996;37:927-935.
5. Murray L, Sinclair D, Cooper P, et al. The socioemotional development of 5-year-old children of postnatally depressed mothers. J Child Psychol Psychiatry 1999;40:1259-1271.
6. Kahn RS, Zuckerman B, Bauchner H, et al. Women's health after pregnancy and child outcomes at age 3 years: a prospective cohort study. Am J Public Health 2002;92:1312-1318.
7. O'Hara MW, Stuart S, Gorman LL, et al. Efficacy of interpersonal psychotherapy for postpartum depression. Arch Gen Psychiatry 2000;57:1039-1045.
8. Appleby L, Warner R, Whitton A, et al. A controlled study of fluoxetine and cognitive-behavioral counseling in the treatment of postnatal depression. BMJ 1997;314:932-936.
9. Murray L, Cooper PJ, Wilson A, et al. Controlled trial of the short- and long-term effect of psychological treatment of post-partum depression: 2. Impact on the mother-child relationship and child outcome. Br J Psychiatry 2003;182:420-427.
10. Cohen LS, Viguera AC, Bouffard SM, et al. Venlafaxine in the treatment of postpartum depression. J Clin Psychiatry 2001;62:592-596.
11. Suri R, Burt VK, Altshuler LL, et al. Fluvoxamine for postpartum depression. Am J Psychiatry 2001;158:1739-1740.
12. Bagedahl-Strindlund M, Monsen BK. Postnatal depression: A hidden illness. Acta Psychiatr Scand 1998;98:272-275.
13. Morris-Rush JK, Freda MC, Bernstein PS. Screening for postpartum depression in an inner-city population. Am J Obstet Gynecol 2003;188:1217-1219.
14. Heneghan AM, Silver EJ, Bauman LJ, et al. Do pediatricians recognize mothers with depressive symptoms? Pediatrics 2000;106:1367-1373.
15. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders-IV-TR, 4th edition. American Psychiatric Publishing, Washington, DC, 2000.
16. Cox JL, Holden JM, Sagovsky R. Detection of postnatal depression. Development of the 10-item Edinburgh Postnatal Depression Scale. Br J Psychiatry 1987;150:782-786.
17. Beck CT, Gable RK. Postpartum Depression Screening Scale: development and psychometric testing. Nurs Res 2000;49:272-282.
18. Beck CT, Gable RK. Comparative analysis of the performance of the Postpartum Depression Screening Scale with two other depression instruments. Nurs Res 2001;50:242-250.
19. Beck CT, Gable RK. Further validation of the Post-partum Depression Screening Scale. Nurs Res 2001;50:155-164.
20. Chaudron LH, Klein MH, Remington P, et al. Predictors, prodromes and incidence of postpartum depression. J Psychosom Obstet Gynecol 2001;22:103-112.
21. Wisner KL, Peindl KS, Gigliotti T, et al. Obsessions and compulsions in women with postpartum depression. J Clin Psychiatry 1999;60:176-180.
22. Spinelli MG. A systematic investigation of 16 cases of neonaticide [see comment]. Am J Psychiatry 2001;158:811-813.
23. Sinclair D, Murray L. Effects of postnatal depression on children's adjustment to school. Teacher's reports. Br J Psychiatry 1998;172:58-63.
24. Weissman MM, Pilowsky DJ, Wickramaratne PJ, et al. Remissions in maternal depression and child psychopathology: a STAR*D-child report. JAMA 2006;295:1389-1398.
25. Scariati PD, Grummer-Strawn LM, Fein SB. A longitudinal analysis of infant morbidity and the extent of breastfeeding in the United States. Pediatrics 1997;99:e5.
26. Dell S, To T. Breastfeeding and asthma in young children: findings from a population-based study. Arch Pediatr Adolesc Med 2001;155:1261-1265.
27. Dignam DM. Understanding intimacy as experienced by breastfeeding women. Health Care Women Int 1995;16:477-485.
28. Burt VK, Suri R, Altshuler L, et al. The use of psychotropic medications during breast-feeding. Am J Psychiatry 2001;158:1001-1009.
29. Hendrick V, Burt VK, Altshuler LL. Psychotropic guidelines for breast-feeding mothers. Am J Psychiatry 1996;153:1236-1237.
30. Weissman AM, Levy BT, Hartz AJ, et al. Pooled analysis of antidepressant levels in lactating mothers, breast milk, and nursing infants. Am J Psychiatry 2004;161:1066-1078.
31. Misri S, Kim J, Riggs KW, et al. Paroxetine levels in postpartum depressed women, breast milk, and infant serum. J Clin Psychiatry 2000;61:828-832.
32. Stowe ZN, Cohen LS, Hostetter A, et al. Paroxetine in human breast milk and nursing infants. Am J Psychiatry 2000;157:185-189.
33. Berle JO, Steen VM, Aamo TO, et al. Breastfeeding during maternal antidepressant treatment with serotonin reuptake inhibitors: Infant exposure, clinical symptoms, and cytochrome p450 genotypes. J Clin Psychiatry 2004;65:1228-1234.
34. Epperson CN, Anderson GM, McDougle CJ. Sertraline and breast-feeding. N Engl J Med 1997;336:1189-1190.
35. Stowe ZN, Owens MJ, Landry JC, et al. Sertraline and desmethylsertraline in human breast milk and nursing infants. Am J Psychiatry 1997;154:1255-1260.
36. Epperson N, Czarkowski KA, Ward-O'Brien D, et al. Maternal sertraline treatment and serotonin transport in breast-feeding mother-infant pairs. Am J Psychiatry 2001;158:1631-1637.
37. Wisner KL, Perel JM, Blumer J. Serum sertraline and N-desmethylsertraline levels in breast-feeding mother-infant pairs. Am J Psychiatry 1998;155:690-692.
38. Dodd S, Stocky A, Buist A, et al. Sertraline analysis in the plasma of breast-fed infants. Aust N Z J Psychiatry 2001;35:545-546.
39. Ito S, Koren G. Antidepressants and breast-feeding [see comment]. Am J Psychiatry 1997;154:1174.
40. Kristensen JH, Ilett KF, Hackett LP, et al. Distribution and excretion of fluoxetine and norfluoxetine in human milk. Br J Clin Pharmacol 1999;48:521-527.
41. Epperson CN, Jatlow PI, Czarkowski K, et al. Maternal fluoxetine treatment in the postpartum period: Effects on platelet serotonin and plasma drug levels in breastfeeding mother-infant pairs. Pediatrics 2003;112:e425.
42. Heikkinen T, Ekblad U, Palo P, et al. Pharmacokinetics of fluoxetine and norfluoxetine in pregnancy and lactation. Clin Pharmacol Ther 2003;73:330-337.
43. Hendrick V, Stowe ZN, Altshuler LL, et al. Fluoxetine and norfluoxetine concentrations in nursing infants and breast milk. Biol Psychiatry 2001;50:775-782.
44. Suri R, Stowe ZN, Hendrick V, et al. Estimates of nursing infant daily dose of fluoxetine through breast milk. Biol Psychiatry 2002;52:446-451.
45. Heikkinen T, Ekblad U, Kero P, et al. Citalopram in pregnancy and lactation. Clin Pharmacol Ther 2002;2:184-191.
46. Lee A, Woo J, Ito S. Frequency of infant adverse events that are associated with citalopram use during breastfeeding. Am J Obstet Gynecol 2004;190:218-221.
47. Arnold LM, Suckow RF, Lichtenstein PK. Fluvoxamine concentrations in breast milk and in maternal and infant sera. J Clin Psychopharmacol 2000;20:491-493.
48. Hagg S, Granberg K, Carleborg L. Excretion of fluvoxamine into breast milk. Br J Clin Pharmacol 2000;49:286-288.
49. Hendrick V, Fukuchi A, Altshuler L, et al. Use of sertraline, paroxetine and fluvoxamine by nursing women. Br J Psychiatry 2001;179:163-166.
50. Piontek CM, Wisner KL, Perel JM, et al. Serum fluvoxamine levels in breastfed infants. J Clin Psychiatry 2001;62:111-113.
51. Yoshida K, Smith B, Kumar RC. Fluvoxamine in breast-milk and infant development. Br J Clin Pharmacol 1997;44:210-211.
52. Wright S, Dawling S, Ashford JJ. Excretion of fluvoxamine in breast milk. Br J Clin Pharmacol 1991;31:209.
53. Lester BM, Cucca J, Andreozzi L, et al. Possible association between fluoxetine hydrochloride and colic in an infant. J Am Acad Child Psychiatry 1993;32:1253-1255.
54. Merlob P, Stahl B, Sulkes J. Paroxetine during breastfeeding: Infant weight gain and maternal adherence to counsel. Eur J Pediatr 2004;163:135-139.
55. Schmidt K, Olesen OV, Jensen PN. Citalopram and breast-feeding: Serum concentration and side effects in the infant. Biol Psychiatry 2000;47:164-165.
56. Brent NB, Wisner KL. Fluoxetine and carbamazepine concentrations in a nursing mother/infant pair. Clin Pediatr 1998;37:41-44.
57. Drug Safety Site.com. Fluoxitine. http://drugsafetysite. com/fluoxetine. Last accessed November 27, 2007.
58. Chambers CD, Anderson PO, Thomas RG, et al. Weight gain in infants whose mothers take fluoxetine. Pediatrics 1999;104:e61.
59. Nightingale SL. Fluoxetine labeling revised to identify phenytoin interaction and to recommend against use in nursing mothers. JAMA 1994;271:1067.
60. Wisner KL, Perel JM. Nortriptyline treatment of breast-feeding women. Am J Psychiatry 1996;153:295.
61. Wisner KL, Perel JM. Serum nortriptyline levels in nursing mothers and their infants. Am J Psychiatry 1991;148:1234-1236.
62. Wisner KL, Perel JM, Findling RL, et al. Nortriptyline and its hydroxymetabolites in breastfeeding mothers and newborns. Psychopharmacol Bull 1997;33:249-251.
63. Frey OR, Scheidt P, von Brenndorff AI. Adverse effects in a newborn infant breast-fed by a mother treated with doxepin. Ann Pharmacother 1999;33:690-693.
64. Ilett KF, Kristensen JH, Hackett LP, et al. Distribution of venlafaxine and its O-desmethyl metabolite in human milk and their effects in breastfed infants. Br J Clin Pharmacol 2002;53:17-22.
65. Baab SW, Peindl KS, Piontek CM, et al. Serum bupropion levels in 2 breastfeeding mother-infant pairs. J Clin Psychiatry 2002;63:910-911.
66. Aichhorn WMD, Whitworth ABM, Weiss UMD, et al. Mirtazapine and breast-feeding [letter]. Am J Psychiatry 2004;161:2325.
67. Chaudron LH, Schoenecker CJ. Bupropion and breastfeeding: A case of a possible infant seizure. J Clin Psychiatry 2004;65:881-882.
68. Lee A, Minhas R, Matsuda N, et al. The safety of St. John's wort (Hypericum perforatum) during breastfeeding. J Clin Psychiatry 2003;64:966-968.
69. Freeman MP, Hibbeln JR, Wisner KL, et al. Randomized dose-ranging pilot trial of omega-3 fatty acids for postpartum depression. Acta Psychiatr Scand 2006;113:31-35.
70. Chambers CD, Anderson PO, Thomas RG, et al. Weight gain in infants breastfed by mothers who take fluoxetine. Pediatrics 1999;104:e61.
71. Yoshida K, Smith B, Craggs M, et al. Investigation of pharmacokinetics and of possible adverse effects in infants exposed to tricyclic antidepressants in breastmilk. J Affect Disord 1997;43:225-237.